Hypothyroidism = insufficient thyroid hormone production. Primary (> 95%): thyroid gland failure -TSH high, FT4 low. Central (< 5%): pituitary or hypothalamic disease -TSH low/normal, FT4 low. Hashimoto's thyroiditis (chronic autoimmune) is the #1 cause in iodine-sufficient countries. Other causes: post-RAI, post-thyroidectomy, post-radiation, medications (amiodarone, lithium, checkpoint inhibitors), iodine deficiency (worldwide), infiltrative (sarcoidosis, hemochromatosis). Prevalence: 5-10% (overt + subclinical). Subclinical hypothyroidism: TSH elevated (4.5-10), FT4 normal. Treatment controversial -treat if: TSH > 10, symptoms, pregnancy/planning pregnancy, positive TPO antibodies with TSH > 7. Symptoms: fatigue, cold intolerance, weight gain, constipation, dry skin, hair loss, menorrhagia, depression, myalgias, delayed DTRs.
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Levothyroxine (T4) | 1.6 mcg/kg/day (full dose); start 25-50 mcg in elderly | PO | Standard of care. Empty stomach, 30-60 min before breakfast. Separate from Ca, Fe, PPI by 4h. Half-life 7 days → steady state in 6 wk. ATA, 2014 |
| Liothyronine (T3) | 5-25 mcg daily (divided BID-TID) | PO | NOT routine. Short half-life → TID dosing. Consider only if persistent symptoms on adequate T4 with normal TSH. Variable absorption. |
| IV levothyroxine | 50-100% of oral dose | IV | For patients who cannot take PO (ICU, post-surgical). 100% bioavailable vs ~70% PO. For myxedema coma: loading dose 200-400 mcg. |
Patient: 38F with fatigue, weight gain (12 lb/6 months), constipation, cold intolerance, and menorrhagia. TSH 62 mIU/L, FT4 0.3 ng/dL. TPO Ab 580 IU/mL. No goiter.
Key findings: Overt primary hypothyroidism (elevated TSH + low FT4). Hashimoto thyroiditis confirmed by strongly positive TPO antibodies. Symptomatic.
Management:
Teaching point: In young, healthy patients, start full replacement dose immediately. In elderly or cardiac patients, start low (25-50 mcg) and titrate slowly, rapid correction can precipitate angina or arrhythmia.
Patient: 32F with known Hashimoto's on levothyroxine 75 mcg daily. Newly pregnant (6 weeks). Pre-pregnancy TSH 1.8. Current TSH 4.2, FT4 0.8 ng/dL.
Key findings: TSH above pregnancy target (< 2.5 in first trimester per ATA 2017). Fetal thyroid doesn't function until week 12, fetus depends entirely on maternal T4 for neurodevelopment.
Management:
Teaching point: Pregnancy increases T4 demand by 25-50% due to increased TBG, plasma volume expansion, and placental deiodinase. The "2 extra tablets per week" rule is a practical way to increase dose ~30% immediately.
Patient: 72F brought by EMS. Found unresponsive at home. Temp 33.2°C, HR 42, BP 82/50, RR 8. Known hypothyroidism, ran out of levothyroxine 3 months ago. Na 118, glucose 48.
Key findings: Myxedema coma: hypothermia + bradycardia + AMS + hypotension in the setting of severe hypothyroidism. Precipitated by medication non-compliance. Mortality 30-60%.
Management:
Teaching point: Always give stress-dose steroids BEFORE or WITH IV levothyroxine in myxedema coma. If undiagnosed adrenal insufficiency coexists (Schmidt syndrome), T4 alone can precipitate adrenal crisis.
Mrs. Johnson is a 45-year-old woman with 6 months of fatigue, 10 lb weight gain, constipation, cold intolerance, and hair thinning. PMH: nothing. No medications. Exam: dry skin, periorbital puffiness, bradycardia (HR 56), delayed DTR relaxation. No goiter. Labs: TSH 48 mIU/L (elevated), Free T4 0.4 ng/dL (low), TPO Ab 420 IU/mL (strongly positive).